[ Price : $8.95]
The Trump Administration fires hundreds of FDA probationary employees over the weekend as part of its efforts to trim government f...[ Price : $8.95]
FDA approves a Deciphera Pharmaceuticals NDA for Romvimza (vimseltinib) for treating adult patients with symptomatic tenosynovial ...[ Price : $8.95]
Based on partially successful Phase 2 study results, AlgoTx says it plans to continue developing ATX01 for chemotherapy-induced pe...[ Price : $8.95]
FDA accepts for priority review a Gilead Sciences NDA for lenacapavir for twice-yearly use in preventing HIV as pre-exposure proph...[ Price : $8.95]
Citizens MAHA files a petition asking HHS and FDA to suspend and revoke EUAs and BLAs for mRNA Covid-19 vaccines and conduct a ful...[ Price : $8.95]
Editor Jim Dickinson posts his obituary of Larry R. Pilot (84), who co-founded FDAs first medical device bureau and parlayed his i...[ Price : $8.95]
The Trump administration adds a gender ideology statement to two Web pages on draft guidances that FDA was ordered by a federal ju...[ Price : $8.95]
Bristol Myers Squibb says a Phase 3 trial evaluating Opdualag (nivolumab and relatlimab-rmbw) for treating patients with completel...